LASEMOX-LP Eye Drops

Composition
Moxifloxacin & Loteprednol Etabonate Eve Drops

Manufacture
Akums Drugs & Pharmaceuticals Ltd.

Composition:
Moxifloxacin Hydrochloride eq. to Moxifloxacin  0.5% w/v
Loteprednol Etabonate  0.5% w/v
Benzalkonium Chloride Solution IP 0.02% v/v
(As preservative)
Sterile aqueous buffered vehicle  q.s.
 
Storage:
Store below 30°C. Protect from light & moisture. Do not freeze.

Warning:
(i) If irritation persists or increases, discontinue the use and consult the Physician.
(ii) Do not touch the nozzle tip or other dispensing tip to any surface since this may contaminate the suspension.
(iii) Use the suspension within one month after opening the container.-If the suspension becomes cloudy or dark brown, it should be discarded.
(iv) Indiscriminate and prolonged use of the ophthalmic preparation containing corticosteroids may lead to glaucoma, cataract and fungal infections.